As neurodegenerative and neuroinflammatory disorders continue to challenge clinicians and researchers alike, the tools we use to detect, understand, and treat them are rapidly evolving. From molecular interventions to digital diagnostics, recent studies highlight the importance of both precision medicine and real-world data in advancing brain health.

One study shows how farrerol, a plant-derived compound, may aid recovery after spinal cord injury by calming inflammation and promoting a reparative immune environment. Meanwhile, researchers are rethinking how we classify and monitor Alzheimer’s disease—proposing that digital tools like sensor-based assessments could improve how we track cognitive function in real-world settings. And in behavioral variant frontotemporal dementia, advanced MRI and diffusion tensor imaging reveal patterns of brain degeneration that connect seemingly distinct syndromes across a shared continuum. Together, these studies reflect a growing shift toward integrated, multi-modal approaches that blend biology, technology, and clinical relevance to better serve patients.